These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7874883)

  • 41. [Antibacterial activity in vitro of 10 quinolones against 20 strains of Legionella pneumophila].
    Deforges L; Fournet MP; Soussy CJ; Duval J
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):631-3. PubMed ID: 3534757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria.
    Nord CE
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S15-8. PubMed ID: 8953101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative susceptibility of Legionella pneumophila and Legionella longbeachae to 12 antimicrobial agents.
    Nimmo GR; Bull JZ
    J Antimicrob Chemother; 1995 Jul; 36(1):219-23. PubMed ID: 8537269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of lomefloxacin (SC 47111 or NY-198) against isolates of Legionella spp.
    Dubois J; Joly JR
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):89S-91S. PubMed ID: 2791504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative in-vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD131501) and reference antimicrobial agents.
    Louie A; Baltch AL; Ritz WJ; Smith RP
    J Antimicrob Chemother; 1991 Jun; 27(6):793-9. PubMed ID: 1657857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
    Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
    Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of a new method for susceptibility testing against fastidious and unusual bacteria].
    Kawakami S; Ono Y; Kato J; Miyazawa Y
    Kansenshogaku Zasshi; 1998 Oct; 72(10):1017-26. PubMed ID: 9847518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fundamental studies on legionellosis--the growth with in Acanthamoeba sp. and antibiotics susceptibility of Legionella spp. isolated from soil samples in Japan].
    Furuhata K; Miyamoto H; Hara M; Fukuyama M
    Kansenshogaku Zasshi; 2003 Feb; 77(2):83-8. PubMed ID: 12661083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in vivo activities of sparfloxacin in Legionella infections.
    Saito A; Gaja M
    Drugs; 1995; 49 Suppl 2():250-2. PubMed ID: 8549320
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin.
    Martin SJ; Pendland SL; Chen C; Schreckenberger PC; Danziger LH
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):167-71. PubMed ID: 9401809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of antibiotic susceptibility of Legionella pneumophila isolated from water systems in Poland.
    Sikora A; Gładysz I; Kozioł-Montewka M; Wójtowicz-Bobin M; Stańczak T; Matuszewska R; Krogulska B
    Ann Agric Environ Med; 2017 Mar; 24(1):66-69. PubMed ID: 28378991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Performance characteristics of newer MIC gradient strip tests compared with the Etest for antimicrobial susceptibility testing of Neisseria gonorrhoeae.
    Jönsson A; Jacobsson S; Foerster S; Cole MJ; Unemo M
    APMIS; 2018 Oct; 126(10):822-827. PubMed ID: 30191618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds.
    Jones RN; Barrett MS; Erwin ME; Briggs BM; Johnson DM
    Diagn Microbiol Infect Dis; 1991; 14(4):319-30. PubMed ID: 1909615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and mechanism of fluoroquinolone resistance in Legionella pneumophila.
    Jonas D; Engels I; Hartung D; Beyersmann J; Frank U; Daschner FD
    J Antimicrob Chemother; 2003 Feb; 51(2):275-80. PubMed ID: 12562691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the Etest and agar dilution for in vitro antimicrobial susceptibility testing of Campylobacter.
    Ge B; Bodeis S; Walker RD; White DG; Zhao S; McDermott PF; Meng J
    J Antimicrob Chemother; 2002 Oct; 50(4):487-94. PubMed ID: 12356792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antimicrobial susceptibility patterns of Legionella isolates in the environment and in patients].
    Choi GE; Kang JE; Lee EY; Chang CL; Tateda K; Yamaguchi K; Kim KH; Kim JM
    Korean J Lab Med; 2010 Feb; 30(1):28-33. PubMed ID: 20197719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent.
    Cooper MA; Andrews JM; Ashby JP; Matthews RS; Wise R
    J Antimicrob Chemother; 1990 Nov; 26(5):667-76. PubMed ID: 2079449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Performance of the Oxoid M.I.C.Evaluator Strips compared with the Etest assay and BSAC agar dilution.
    Mushtaq S; Warner M; Cloke J; Afzal-Shah M; Livermore DM
    J Antimicrob Chemother; 2010 Aug; 65(8):1702-11. PubMed ID: 20562429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
    García-Rodríguez JA; García-Sánchez JE; Trujillano-Martín I; García-Sánchez E; García-García MI; Fresnadillo-Martínez MJ
    J Chemother; 1995 Jun; 7(3):189-96. PubMed ID: 7562012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.